Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$33.8 -0.16 | -0.47%
10/31/14 - 12:50 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 80.86M 85.38M 61.25M 66.24M
Cost of Sales 6.12M 8.33M 4.36M 3.52M
Gross Operating Profit 74.74M 77.05M 56.89M 62.72M
Selling, General, and Administrative Expenses 59.95M 53.07M 68.86M 84.94M
Research & Development 20.56M 33.30M 58.14M 54.46M
Operating Income before D & A (EBITDA) -5.77M -9.32M -70.11M -76.68M
Depreciation & Amortization 5.84M 5.89M 6.18M 4.08M
Interest Income 1.05M 1.29M 1.75M 1.74M
Other Income - Net 964.00K -1.47M -193.00K -380.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -9.60M -17.60M -78.24M -81.62M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -9.60M -17.60M -78.24M -81.62M
Income Taxes 0.00 -854.00K -1.17M -472.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -9.60M -16.75M -77.07M -81.15M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -9.60M -16.75M -77.07M -81.15M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -9.60M -16.75M -77.07M -81.15M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-9.60M -14.54M -73.56M -78.93M
Preferred Dividends
Net Income Available To Common -9.60M -16.75M -77.07M -81.15M
Basic EPS from Continuing Ops. -0.44 -0.78 -3.64 -3.90
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.44 -0.78 -3.64 -3.90
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.44 -0.78 -3.64 -3.90
Basic Normalized Net Income/Share -0.44 -0.68 -3.47 -3.79
EPS fr Continuing Ops. -0.44 -0.78 -3.64 -3.90
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.44 -0.78 -3.64 -3.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.44 -0.78 -3.64 -3.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.44 -0.68 -3.47 -3.79
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter